| abstract |
The present disclosure relates to chimeric respiratory syncytial virus (RSV), herbalized vaccine and immunogenic compositions, and methods of use. In certain embodiments, the chimeric respiratory cell fusion virus has a mutated gene pattern encoding RSV F protein having M at position 79, R at position 191, K at position 357, and Y at position 371 . |